Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 24, 2022

SELL
$13.17 - $16.4 $219,952 - $273,896
-16,701 Closed
0 $0
Q3 2021

Oct 21, 2021

SELL
$16.3 - $17.26 $4,335 - $4,591
-266 Reduced 1.57%
16,701 $274,000
Q4 2020

Feb 02, 2021

SELL
$15.39 - $18.97 $38,736 - $47,747
-2,517 Reduced 12.92%
16,967 $309,000
Q2 2020

Aug 10, 2020

SELL
$14.59 - $19.5 $18,354 - $24,531
-1,258 Reduced 6.06%
19,484 $349,000
Q1 2020

May 04, 2020

SELL
$13.02 - $20.31 $3,268 - $5,097
-251 Reduced 1.2%
20,742 $315,000
Q4 2019

Feb 04, 2020

BUY
$16.88 - $20.83 $354,361 - $437,284
20,993 New
20,993 $414,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Sky Oak Wealth, LLC Portfolio

Follow Sky Oak Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sky Oak Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sky Oak Wealth, LLC with notifications on news.